Myostatin and markers of bone metabolism in dermatomyositis
Abstract Background In dermatomyostis (DM) patients, inflammation, reduced activity, and medication have a negative impact on the musculoskeletal system. Several endocrine factors are involved in muscle growth and bone turnover. Objective: We aimed to investigate factors regulating myogenesis and bo...
Main Authors: | Katharina Kerschan-Schindl, Wolfgang Gruther, Ursula Föger-Samwald, Christine Bangert, Stefan Kudlacek, Peter Pietschmann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-021-04030-0 |
Similar Items
-
High serum myostatin level suggests accelerated muscle senescence in active idiopathic inflammatory myositis
by: Anamika Kumari Anuja, et al.
Published: (2021-01-01) -
A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse
by: Kepeng Ou, et al.
Published: (2020-08-01) -
Myostatin/Appendicular Skeletal Muscle Mass (ASM) Ratio, Not Myostatin, Is Associated with Low Handgrip Strength in Community-Dwelling Older Women
by: Soo Jeong Choi, et al.
Published: (2021-07-01) -
JUVENILE DERMATOMYOSITIS
by: Sigrid Covaci, et al.
Published: (2016-12-01) -
ESTRADIOL IN FEMALES MAY NEGATE SKELETAL MUSCLE MYOSTATIN MRNA EXPRESSION AND SERUM MYOSTATIN PROPEPTIDE LEVELS AFTER ECCENTRIC MUSCLE CONTRACTIONS
by: Darryn S. Willoughby, et al.
Published: (2006-12-01)